Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis

BACKGROUND: ‘No evidence of disease activity’ (NEDA), defined as absence of magnetic resonance imaging activity (T2 and/or gadolinium-enhanced T1 lesions), relapses and disability progression (‘NEDA-3’), is used as a comprehensive measure of treatment response in relapsing multiple sclerosis (RMS),...

Descripción completa

Detalles Bibliográficos
Autores principales: Kappos, Ludwig, De Stefano, Nicola, Freedman, Mark S, Cree, Bruce AC, Radue, Ernst-Wilhelm, Sprenger, Till, Sormani, Maria Pia, Smith, Terence, Häring, Dieter A, Piani Meier, Daniela, Tomic, Davorka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015759/
https://www.ncbi.nlm.nih.gov/pubmed/26585439
http://dx.doi.org/10.1177/1352458515616701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015759/
https://www.ncbi.nlm.nih.gov/pubmed/26585439
http://dx.doi.org/10.1177/1352458515616701

Ejemplares similares